Search
Returning search results with filters:
Remove filter for
Category: Drugs
Remove filter for
Type: Alert
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 106 - 120 of 283 items.
Unauthorized nicotine buccal pouches may pose serious health risks
AlertPublic advisory | 2020-11-02
Updates to safety labelling for benzodiazepines and benzodiazepine-like drugs
AlertPublic advisory | 2020-10-30
Recalls of Regener-Eyes Ophthalmic Solution and Regener-Eyes Ophthalmic Solution Lite
AlertPublic advisory | 2020-10-30
PICATO (ingenol mebutate gel, 0.015% and 0.05%) - Product Withdrawal in Canada due to Potential Increased Risk of Skin Cancer
AlertHealth professional risk communication | 2020-10-27
LEO Pharma Inc. is withdrawing the drug Picato (Ingenol mebutate), used to treat skin lesions, due to the potential increased risk of skin cancer
AlertInformation update | 2020-10-27
Benzocaine-Containing Products and the Risk of Methemoglobinemia in Children under Two Years of Age
AlertHealth professional risk communication | 2020-10-22
Unauthorized products may pose serious health risks (October 21, 2020)
AlertPublic advisory | 2020-10-21
An unauthorized biologic eye drop, Regener-Eyes Ophthalmic Solution, recalled after Edmonton clinic found to be importing and selling it
AlertPublic advisory | 2020-10-04
FIBRISTAL (ulipristal acetate tablets, 5 mg) - Voluntary Withdrawal in Canada due to Risk of Drug-Induced Liver Injury
AlertHealth professional risk communication | 2020-09-30
Allergan Inc. voluntarily withdraws its drug Fibristal, used to treat uterine fibroids, from the Canadian market
AlertPublic advisory | 2020-09-30
All strengths of MAR-Diltiazem CD, a drug used to treat angina and hypertension, have been recalled because of dosing concerns
AlertPublic advisory | 2020-09-24
Unauthorized health products sold on Steroid Hub Canada website may pose serious health risks
AlertPublic advisory | 2020-09-18
Unauthorized products may pose serious health risks (September 16, 2020: Part 1)
AlertPublic advisory | 2020-09-16